ALPHA TAU MEDICAL news, videos and press releases
For more news please use our advanced search feature.
ALPHA TAU MEDICAL - More news...
ALPHA TAU MEDICAL - More news...
- Alpha Tau to Present at the Jefferies Global Healthcare Conference
- Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
- Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
- Alpha Tau to Participate in May Investor Conferences
- Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
- Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
- Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
- Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Alpha Tau to Participate in Sidoti Small-Cap Conference
- Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
- Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
- Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Alpha Tau to Participate in November Investor Conferences
- Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
- Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
- Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
- Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
- Alpha Tau Medical to Participate in September Investor Conferences
- Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
- Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023
- Alpha Tau Medical to Participate in June Investor Conferences
- Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update
- Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
- Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open
- Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
- Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
- Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit
- Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank
- Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update
